Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Larson, SM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 233 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Nakakushi, T; Akabane, T; Iwasaki, K; Larson, SM
      Mars: The cloud effect on the blue clearing in the Syrtis Major region

      JOURNAL OF GEOPHYSICAL RESEARCH-PLANETS
    2. Burt, BM; Humm, JL; Kooby, DA; Squire, OD; Mastorides, S; Larson, SM; Fong, YM
      Using positron emission tomography with [F-18]FDG to predict tumor behavior in experimental colorectal cancer

      NEOPLASIA
    3. Bennett, JJ; Tjuvajev, J; Johnson, P; Doubrovin, M; Akhurst, T; Malholtra, S; Hackman, T; Balatoni, J; Finn, R; Larson, SM; Federoff, H; Blasberg, R; Fong, YM
      Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer

      NATURE MEDICINE
    4. Gorlick, R; Liao, AC; Antonescu, C; Huvos, AG; Healey, JH; Sowers, R; Daras, M; Calleja, E; Wexler, LH; Panicek, D; Meyers, PA; Yeh, SD; Larson, SM
      Lack of correlation of functional scintigraphy with (99m)technetium-methoxyisobutylisonitrile with histological necrosis following induction chemotherapy or measures of P-Glycoprotein expression in high-grade osteosarcoma

      CLINICAL CANCER RESEARCH
    5. Robbins, RJ; Tuttle, RM; Sonenberg, M; Shaha, A; Sharaf, R; Robbins, H; Fleisher, M; Larson, SM
      Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin

      THYROID
    6. Kushner, BH; Yeung, HWD; Larson, SM; Kramer, K; Cheung, NKV
      Extending positron emission tomography scan utility to high-risk neuroblastoma: Fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients

      JOURNAL OF CLINICAL ONCOLOGY
    7. Ramos, CD; Chisin, R; Yeung, HWD; Larson, SM; Macapinlac, HA
      Incidental focal thyroid uptake on FDG positron emission tomographic scansmay represent a second primary tumor

      CLINICAL NUCLEAR MEDICINE
    8. Ramos, CD; Erdi, YE; Gonen, M; Riedel, E; Yeung, HWD; Macapinlac, HA; Chisin, R; Larson, SM
      FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    9. Tanswell, P; Garin-Chesa, P; Rettig, WJ; Welt, S; Divgi, CR; Casper, ES; Finn, RD; Larson, SM; Old, LJ; Scott, AM
      Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    10. Dillner, AM; Stein, C; Larson, SM; Hitzenberger, R
      Measuring the mass extinction efficiency of elemental carbon in rural aerosol

      AEROSOL SCIENCE AND TECHNOLOGY
    11. Barendswaard, EC; Humm, JL; O'Donoghue, JA; Sgouros, G; Finn, RD; Scott, AM; Larson, SM; Welt, S
      Relative therapeutic efficacy of I-125- and I-131-labeled monoclonal antibody A33 in a human colon cancer xenograft

      JOURNAL OF NUCLEAR MEDICINE
    12. Lovqvist, A; Humm, JL; Sheikh, A; Finn, RD; Koziorowski, J; Ruan, S; Pentlow, KS; Jungbluth, A; Welt, S; Lee, FT; Brechbiel, MW; Larson, SM
      PET imaging of Y-86-labeled anti-Lewis Y monoclonal antibodies in a nude mouse model: Comparison between Y-86 and In-111 radiolabels

      JOURNAL OF NUCLEAR MEDICINE
    13. Yeung, HWD; Humm, JL; Larson, SM
      Thyroid stunning - Reply

      JOURNAL OF NUCLEAR MEDICINE
    14. Yeung, HWD; Cody, HS; Turlakow, A; Riedel, ER; Fey, J; Gonen, M; Nunez, R; Yeh, SD; Larson, SM
      Lymphoscintigraphy and sentinel node localization in breast cancer patients: A comparison between 1-day and 2-day protocols

      JOURNAL OF NUCLEAR MEDICINE
    15. Kolbert, KS; Hamacher, KA; Jurcic, JG; Scheinberg, DA; Larson, SM; Sgouros, G
      Parametric images of antibody pharmacokinetics in Bi213-HuM195 therapy of leukemia

      JOURNAL OF NUCLEAR MEDICINE
    16. Kramer, K; Gerald, WL; Kushner, BH; Larson, SM; Hameed, M; Cheung, NKV
      Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma

      MEDICAL AND PEDIATRIC ONCOLOGY
    17. Cheung, NKV; Kushner, BH; LaQuaglia, M; Kramer, K; Gollamudi, S; Heller, G; Gerald, W; Yeh, S; Finn, R; Larson, SM; Wuest, D; Byrnes, M; Dantis, E; Mora, J; Cheung, IY; Rosenfield, N; Abramson, S; O'Reilly, RJ
      N7: A novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age

      MEDICAL AND PEDIATRIC ONCOLOGY
    18. Gonen, M; Panageas, KS; Larson, SM
      Statistical issues in analysis of diagnostic imaging experiments with multiple observations per patient

      RADIOLOGY
    19. Robbins, RJ; Tuttle, RM; Sharaf, RN; Larson, SM; Robbins, HK; Ghossein, RA; Smith, A; Drucker, WD
      Preparation by recombinant human thyrotropin or thyroid hormone withdrawalare comparable for the detection of residual differentiated thyroid carcinoma

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    20. Kerola, DX; Larson, SM
      Analysis of coma dust optical properties in Comet C/1995 O1 (Hale-Bopp) II. Effects of polarization

      ICARUS
    21. Jacobs, A; Tjuvajev, JG; Dubrovin, M; Akhurst, T; Balatoni, J; Beattie, B; Joshi, R; Finn, R; Larson, SM; Herrlinger, U; Pechan, PA; Chiocca, EA; Breakefield, XO; Blasberg, RG
      Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo

      CANCER RESEARCH
    22. Turlakow, A; Yeung, HWD; Pui, J; Macapinlac, H; Liebovitz, E; Rusch, V; Goy, A; Larson, SM
      Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis

      ARCHIVES OF INTERNAL MEDICINE
    23. Gambhir, SS; Herschman, HR; Cherry, SR; Barrio, JR; Satyamurthy, N; Toyokuni, T; Phelps, ME; Larson, SM; Balatoni, J; Finn, R; Sadelain, M; Tjuvajev, J; Blasberg, R
      Imaging transgene expression with radionuclide imaging technologies

      NEOPLASIA
    24. Larson, SM
      Molecular imaging in oncology: The diagnostic imaging "revolution"

      CLINICAL CANCER RESEARCH
    25. Pittas, AG; Adler, M; Fazzari, M; Tickoo, S; Rosai, J; Larson, SM; Robbins, RJ
      Bone metastases from thyroid carcinoma: Clinical characteristics and prognostic variables in one hundred forty-six patients

      THYROID
    26. Robbins, RJ; Hill, RH; Wang, WP; Macapinlac, HH; Larson, SM
      Inhibition of metabolic activity in papillary thyroid carcinoma by a somatostatin analogue

      THYROID
    27. Larson, SM; Davidson, AR
      The identification of conserved interactions within the SH3 domain by alignment of sequences and structures

      PROTEIN SCIENCE
    28. Nunez, RF; Yeung, HWD; Macapinlac, HA; Castro-Malaspina, H; Larson, SM
      Ga-67 uptake in cutaneous lesions of graft-versus-host disease

      CLINICAL NUCLEAR MEDICINE
    29. Erdi, YE; Macapinlac, H; Rosenzweig, KE; Humm, JL; Larson, SM; Erdi, AK; Yorke, ED
      Use of PET to monitor the response of lung cancer to radiation treatment

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    30. Yeung, HWD; Humm, JL; Larson, SM
      Radioiodine uptake in thyroid remnants during therapy after tracer dosimetry

      JOURNAL OF NUCLEAR MEDICINE
    31. Levchenko, A; Mehta, BM; Lee, JB; Humm, JL; Augensen, F; Squire, O; Kothari, PJ; Finn, RD; Leonard, EF; Larson, SM
      Evaluation of C-11-colchicine for PET imaging of multiple drug resistance

      JOURNAL OF NUCLEAR MEDICINE
    32. Ruan, S; O'Donoghue, JA; Larson, SM; Finn, RD; Jungbluth, A; Welt, S; Humm, JL
      Optimizing the sequence of combination therapy with radiolabeled antibodies and fractionated external beam

      JOURNAL OF NUCLEAR MEDICINE
    33. Kramer, K; Cheung, NKV; Humm, JL; Dantis, E; Finn, R; Yeh, SJ; Antunes, NL; Dunker, IJ; Souwedaine, M; Larson, SM
      Targeted radioimmunotherapy for leptomeningeal cancer using I-131-3F8

      MEDICAL AND PEDIATRIC ONCOLOGY
    34. DiResta, GR; Lee, J; Healey, JH; Levchenko, A; Larson, SM; Arbit, E
      "Artificial lymphatic system": A new approach to reduce interstitial hypertension and increase blood flow, pH and pO(2) in solid tumors

      ANNALS OF BIOMEDICAL ENGINEERING
    35. DiResta, GR; Lee, J; Healey, JH; Larson, SM; Arbit, E
      Enhancing the uptake of chemotherapeutic drugs into tumors using an "artificial lymphatic system"

      ANNALS OF BIOMEDICAL ENGINEERING
    36. Larson, SM; Di Nardo, AA; Davidson, AR
      Analysis of covariation in an SH3 domain sequence alignment: Applications in tertiary contact prediction and the design of compensating hydrophobic core substitutions

      JOURNAL OF MOLECULAR BIOLOGY
    37. Wang, WP; Larson, SM; Fazzari, M; Tickoo, SK; Kolbert, K; Sgouros, G; Yeung, H; Macapinlac, H; Rosai, J; Robbins, RJ
      Prognostic value of [F-18]fluorodeoxyglucose positron emission tomographicscanning in patients with thyroid cancer

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    38. Jarvis, KS; Vilas, F; Larson, SM; Gaffey, MJ
      Are Hyperion and Phoebe linked to Lapetus?

      ICARUS
    39. Jarvis, KS; Vilas, F; Larson, SM; Gaffey, MJ
      JVI Himalia: New compositional evidence and interpretations for the originof Jupiter's small satellites

      ICARUS
    40. Tickoo, SK; Pittas, AG; Adler, M; Fazzari, M; Larson, SM; Robbins, RJ; Rosai, J
      Bone metastases from thyroid carcinoma - A histopathologic study with clinical correlates

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    41. Reuland, P; Larson, SM
      Endocrine/neuroendocrine tumors

      PET IN CLINICAL ONCOLOGY
    42. Omar, AH; Biegalski, S; Larson, SM; Landsberger, S
      Particulate contributions to light extinction and local forcing at a ruralIllinois site

      ATMOSPHERIC ENVIRONMENT
    43. Hitzenberger, R; Berner, A; Giebl, H; Kromp, R; Larson, SM; Rouc, A; Koch, A; Marischka, S; Puxbaum, H
      Contribution of carbonaceous material to cloud condensation nuclei concentrations in European background (Mt. Sonnblick) and urban (Vienna) aerosols

      ATMOSPHERIC ENVIRONMENT
    44. Hitzenberger, R; Jennings, SG; Larson, SM; Dillner, A; Cachier, H; Galambos, Z; Rouc, A; Spain, TG
      Intercomparison of measurement methods for black carbon aerosols

      ATMOSPHERIC ENVIRONMENT
    45. Graham, MC; Scher, HI; Liu, GB; Yeh, SDJ; Curley, T; Daghighian, F; Goldsmith, SJ; Larson, SM
      Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases front androgen-independent prostate cancer

      CLINICAL CANCER RESEARCH
    46. Chaudhry, A; Carrasquillo, JA; Avis, IL; Shuke, N; Reynolds, JC; Bartholomew, R; Larson, SM; Cuttitta, F; Johnson, BE; Mulshine, JL
      Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer

      CLINICAL CANCER RESEARCH
    47. Fonti, R; Cheung, NKV; Bridger, GJ; Guo, HF; Abrams, MJ; Larson, SM
      Tc-99m-Monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors

      NUCLEAR MEDICINE AND BIOLOGY
    48. Fonti, R; Levchenko, A; Mehta, BM; Zhang, JJ; Tsuruo, T; Larson, SM
      Measurement of P-glycoprotein expression in human neuroblastoma xenograftsusing in vitro quantitative autoradiography

      NUCLEAR MEDICINE AND BIOLOGY
    49. Sabbatini, P; Larson, SM; Kremer, A; Zhang, ZF; Sun, M; Yeung, H; Imbriaco, M; Horak, I; Conolly, M; Ding, C; Ouyang, P; Kelly, WK; Scher, HI
      Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer

      JOURNAL OF CLINICAL ONCOLOGY
    50. Sgouros, G; Ballangrud, AM; Jurcic, JG; McDevitt, MR; Humm, JL; Erdi, YE; Mehta, BM; Finn, RD; Larson, SM; Scheinberg, DA
      Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: Bi-213-HuM195 (anti-CD33) in patients with leukemia

      JOURNAL OF NUCLEAR MEDICINE
    51. McDevitt, MR; Finn, RD; Ma, D; Larson, SM; Scheinberg, DA
      Preparation of alpha-emitting Bi-213-labeled antibody constructs for clinical use

      JOURNAL OF NUCLEAR MEDICINE
    52. Barendswaard, EC; O'Donoghue, JA; Larson, SM; Tschmelitsch, J; Welt, S; Finn, RD; Humm, JL
      I-131 radioimmunotherapy and fractionated external beam radiotherapy: Comparative effectiveness in a human tumor xenograft

      JOURNAL OF NUCLEAR MEDICINE
    53. Furhang, EE; Larson, SM; Buranapong, P; Humm, JL
      Thyroid cancer dosimetry using clearance fitting

      JOURNAL OF NUCLEAR MEDICINE
    54. Akhurst, T; Larson, SM
      Positron emission tomography imaging of colorectal cancer

      SEMINARS IN ONCOLOGY
    55. Roter, DL; Geller, G; Bernhardt, BA; Larson, SM; Doksum, T
      Effects of obstetrician gender on communication and patient satisfaction

      OBSTETRICS AND GYNECOLOGY
    56. Wang, WP; Macapinlac, H; Larson, SM; Yeh, SDJ; Akhurst, T; Finn, RD; Rosai, J; Robbins, RJ
      [F-18]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic I-131 whole body scans and elevated serum thyroglobulin levels

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    57. Kerola, DX; Larson, SM
      Adaptation of planetary atmospheres modeling methods for analysis of coma dust optical properties in Comet C/1995 O1 (Hale-Bopp): I

      ICARUS
    58. Fong, YM; Saldinger, PF; Akhurst, T; Macapinlac, H; Yeung, H; Finn, RD; Cohen, A; Kemeny, N; Blumgart, LH; Larson, SM
      Utility of F-18-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases

      AMERICAN JOURNAL OF SURGERY
    59. KRAMER K; GERALD WL; KUSHNER BH; LARSON SM; HAMEED M; CHEUNG NKV
      DISIALOGANGLIOSIDE G(D2) LOSS FOLLOWING MONOCLONAL-ANTIBODY THERAPY IS RARE IN NEUROBLASTOMA

      Clinical cancer research
    60. IMBRIACO M; LARSON SM; YEUNG HW; MAWLAWI OR; ERDI Y; VENKATRAMAN ES; SCHER HI
      A NEW PARAMETER FOR MEASURING METASTATIC BONE INVOLVEMENT BY PROSTATE-CANCER - THE BONE-SCAN INDEX

      Clinical cancer research
    61. SLOVIN SF; SCHER HI; DIVGI CR; REUTER V; SGOUROS G; MOORE M; WEINGARD K; PETTENGALL R; IMBRIACO M; ELSHIRBINY A; FINN R; BRONSTEIN J; BRETT C; MILENIC D; DNISTRIAN A; SHAPIRO L; SCHLOM J; LARSON SM
      INTERFERON-GAMMA AND MONOCLONAL-ANTIBODY I-131-LABELED CC49 - OUTCOMES IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER

      Clinical cancer research
    62. SLOVIN SF; SCHER HI; DIVGI CR; REUTER V; SGOUROS G; MOORE M; WEINGARD K; PETTENGALL R; IMBRIACO M; ELSHIRBINY A; FINN R; BRONSTEIN J; BRETT C; MILENIC D; DNISTRIAN A; SHAPIRO L; SCHLOM J; LARSON SM
      INTERFERON-GAMMA AND MONOCLONAL-ANTIBODY I-131-LABELED CC49 - OUTCOMES IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER

      Clinical cancer research
    63. FOSS FM; RAUBITSCHECK A; MULSHINE JL; FLEISHER TA; REYNOLDS JC; PAIK CH; NEUMANN RD; BOLAND C; PERENTESIS P; BROWN MR; FRINCKE JM; LOLLO CP; LARSON SM; CARRASQUILLO JA
      PHASE-I STUDY OF THE PHARMACOKINETICS OF A RADIOIMMUNOCONJUGATE, Y-90T101, IN PATIENTS WITH CD5-EXPRESSING LEUKEMIA AND LYMPHOMA

      Clinical cancer research
    64. DIVGI CR; BANDER NH; SCOTT AM; ODONOGHUE JA; SGOUROS G; WELT S; FINN RD; MORRISSEY F; CAPITELLI P; WILLIAMS JM; DELAND D; NAKHRE A; OOSTERWIJK E; GULEC S; GRAHAM MC; LARSON SM; OLD LJ
      PHASE I II RADIOIMMUNOTHERAPY TRIAL WITH IODINE-131-LABELED MONOCLONAL-ANTIBODY G250 IN METASTATIC RENAL-CELL CARCINOMA/

      Clinical cancer research
    65. CHEUNG NKV; KUSHNER BH; YEH SDJ; LARSON SM
      3F8 MONOCLONAL-ANTIBODY TREATMENT OF PATIENTS WITH STAGE-4 NEUROBLASTOMA - A PHASE-II STUDY

      International journal of oncology
    66. BARENDSWAARD EC; SCOTT AM; DIVGI CR; WILLIAMS C; COPLAN K; RIEDEL E; YAO TJ; GANSOW OA; FINN RD; LARSON SM; OLD LJ; WELT S
      RAPID AND SPECIFIC TARGETING OF MONOCLONAL-ANTIBODY A33 TO A COLON-CANCER XENOGRAFT IN NUDE-MICE

      International journal of oncology
    67. Cull, P; Larson, SM
      Smaller diameters in hypercube-variant networks

      TELECOMMUNICATION SYSTEMS
    68. CHEUNG NKV; KUSHNER BH; CHEUNG IY; KRAMER K; CANETE A; GERALD W; BONILLA MA; FINN R; YEH SJ; LARSON SM
      ANTI-GD(2) ANTIBODY TREATMENT OF MINIMAL RESIDUAL STAGE-4 NEUROBLASTOMA DIAGNOSED AT MORE THAN 1 YEAR OF AGE

      Journal of clinical oncology
    69. SGOUROS G; ODONOGHUE JA; LARSON SM; MACAPINLAC H; LARSON JJ; KEMENY N
      MATHEMATICAL-MODEL OF 5-[I-125]IODO-2'-DEOXYURIDINE TREATMENT - CONTINUOUS-INFUSION REGIMENS FOR HEPATIC METASTASES

      International journal of radiation oncology, biology, physics
    70. MCDEVITT MR; SGOUROS G; FINN RD; HUMM JL; JURCIC JG; LARSON SM; SCHEINBERG DA
      RADIOIMMUNOTHERAPY WITH ALPHA-EMITTING NUCLIDES

      European journal of nuclear medicine
    71. PENTLOW KS; MAWLAWI O; DAGHIGHIAN F; FINN RD; HUMM JL; LARSON SM
      IMAGING OF TRACER AMOUNTS OF I-124 IN THE PRESENCE OF THERAPEUTIC AMOUNTS OF I-131 WITH A STANDARD PET SCANNER

      The Journal of nuclear medicine
    72. MACAPINLAC HA; HUMM JL; LARSON SM; AKHURST T; SQUIRE OD; PENTLOW K; YEUNG HWD; FINN RD; CAI S; OSMAN I; SCHER H
      DIFFERENTIAL METABOLISM AND PHARMACOKINETICS OF C-11 METHIONINE (C-11-MET) AND FDG IN METASTATIC PROSTATE-CANCER

      The Journal of nuclear medicine
    73. YEUNG HWD; MACAPINLAC H; AKHURST T; KARPEH M; FINN RD; LARSON SM
      ACCURACY OF FDG-PET IN GASTRIC-CANCER - PRELIMINARY EXPERIENCE

      The Journal of nuclear medicine
    74. DAGHIGHIAN F; VALLABHAJOSULA S; BANDER NH; GOLDSMITH SJ; LARSON SM
      LIMIT OF TUMOR-DETECTION USING BETA-PROBE

      The Journal of nuclear medicine
    75. PENTLOW KS; FINN RD; LARSON SM; ERDI YE; HUMM JL
      PHANTOM MEASUREMENTS TO INVESTIGATE THE USE OF YTTRIUM-86 AND PET TO DETERMINE THE IN-VIVO DISTRIBUTION OF YTTRIUIM-90 LABELED PHARMACEUTICALS

      The Journal of nuclear medicine
    76. YEUNG HWD; HUMM JL; LARSON SM
      RADIOIODINE UPTAKE IN THYROID REMNANTS DURING THERAPY FOLLOWING TRACER DOSIMETRY

      The Journal of nuclear medicine
    77. BALLANGRUD AM; HUMM JL; MCDEVITT MR; FINN RD; JURCIC JG; LARSON SM; SCHEINBERG DA; SGOUROS G
      NORMAL ORGAN DOSIMETRY OF LEUKEMIA PATIENTS TREATED WITH HUM195 LABELED WITH THE ALPHA-PARTICLE EMITTER BI-213

      The Journal of nuclear medicine
    78. MCDEVITT MR; FINN RD; LARSON SM; CURCIO MJ; BANDER N; BRECHBIEL MW; SGOUROS G; GEERLINGS MW; BARENDSWAARD E; SCHEINBERG DA
      BISMUTH LABELED ANTIBODIES FOR THERAPY OF PROSTATE CARCINOMAS - PRECLINICAL STUDIES

      The Journal of nuclear medicine
    79. ERDI YE; KALAIGIAN H; LARSON SM; HUMM JL
      WORLDWIDE THYROID DOSIMETRY BY INTERNET USING MEMORIAL SLOAN-KETTERING TREATMENT PROTOCOL

      The Journal of nuclear medicine
    80. LOH A; SGOUROS G; ODONOGHUE JA; DELAND D; PURI D; CAPITELLI P; HUMM JL; LARSON SM; OLD LJ; DIVGI CR
      PHARMACOKINETIC MODEL OF IODINE-131-G250 ANTIBODY IN RENAL-CELL CARCINOMA PATIENTS

      The Journal of nuclear medicine
    81. BERNHARDT BA; GELLER G; DOKSUM T; LARSON SM; ROTER D; HOLTZMAN NA
      PRENATAL GENETIC TESTING - CONTENT OF DISCUSSIONS BETWEEN OBSTETRIC PROVIDERS AND PREGNANT-WOMEN

      Obstetrics and gynecology
    82. Mawlawi, OR; Miodownik, S; Leonard, EF; DiResta, GR; Larson, SM
      A customized motion acquisition circuit for image deblurring in positron emission tomography

      IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT
    83. TJUVAJEV JG; AVRIL N; OKU T; SASAJIMA T; MIYAGAWA T; JOSHI R; SAFER M; BEATTIE B; DIRESTA G; DAGHIGHIAN F; AUGENSEN F; KOUTCHER J; ZWEIT J; HUMM J; LARSON SM; FINN R; BLASBERG R
      IMAGING HERPES-VIRUS THYMIDINE KINASE GENE-TRANSFER AND EXPRESSION BYPOSITRON-EMISSION-TOMOGRAPHY

      Cancer research
    84. RABB MF; LARSON SM; GREGER JR
      AN UNUSUAL CAUSE OF PARTIAL ETT OBSTRUCTION

      Anesthesiology
    85. MACAPINLAC HA; LARSON SM
      POSITRON-EMISSION-TOMOGRAPHY (PET)-MEASURED BIOCHEMICAL RESPONSE TO RADIOTHERAPY OF LARYNGEAL TUMORS

      The cancer journal from Scientific American
    86. FINSTAD CL; LLOYD KO; FEDERICI MG; DIVGI C; VENKATRAMAN E; BARAKAT RR; FINN RD; LARSON SM; HOSKINS WJ; HUMM JL
      DISTRIBUTION OF RADIOLABELED MONOCLONAL-ANTIBODY MX35 F(AB')2 IN TISSUE SAMPLES BY STORAGE PHOSPHOR SCREEN IMAGE-ANALYSIS - EVALUATION OF ANTIBODY LOCALIZATION TO MICROMETASTATIC DISEASE IN EPITHELIAL OVARIAN-CANCER

      Clinical cancer research
    87. CAL MP; ROOD MJ; LARSON SM
      GAS-PHASE ADSORPTION OF VOLATILE ORGANIC-COMPOUNDS AND WATER-VAPOR ONACTIVATED CARBON CLOTH

      Energy & fuels
    88. WU D; LANDSBERGER S; LARSON SM
      DETERMINATION OF THE ELEMENTAL DISTRIBUTION IN CIGARETTE COMPONENTS AND SMOKE BY INSTRUMENTAL NEUTRON-ACTIVATION ANALYSIS

      Journal of radioanalytical and nuclear chemistry
    89. ERDI YE; HUMM JL; IMBRIACO M; YEUNG H; LARSON SM
      QUANTITATIVE BONE METASTASES ANALYSIS BASED ON IMAGE SEGMENTATION

      The Journal of nuclear medicine
    90. ELSHIRBINY AM; YEUNG H; IMBRIACO M; MICHAELI J; MACAPINLAC H; LARSON SM
      TECHNETIUM-99M-MIBI VERSUS FLUORINE-18-FDG IN DIFFUSE MULTIPLE-MYELOMA

      The Journal of nuclear medicine
    91. LARSON SM; TJUVAJEV J; BLASBERG R
      TRIUMPH OVER MISCHANCE - A ROLE FOR NUCLEAR-MEDICINE IN GENE-THERAPY

      The Journal of nuclear medicine
    92. BARENDSWAARD EC; ODONOGHUE JA; LARSON SM; TSCHMELITSCH J; WELT S; SCHLOM J; SCOTT A; HUMM JL
      COMPARISON OF THE EFFECTIVENESS OF RADIOIMMUNOTHERAPY AND FRACTIONATED RADIOTHERAPY

      The Journal of nuclear medicine
    93. ERDI YE; HUMM JL; IMBRIACO M; LARSON SM
      LIMITS OF DETECTABILITY IN THYROID-CARCINOMA - A COMPARATIVE-STUDY OFTC-99M, I-131, AND F-18

      The Journal of nuclear medicine
    94. YEUNG HWD; IMBRIACO M; MACAPINLAC H; ZHANG JJ; GINSBERG R; YOUNG C; FINN RD; LARSON SM
      ACCURACY OF FDG-PET IN PATIENTS WITH LUNG-TUMOR AND COMPARISON WITH CT

      The Journal of nuclear medicine
    95. SGOUROS G; ODONOGHUE JA; LARSON SM; MACAPINLAC H; LARSON JJ; KEMENY N
      MATHEMATICAL-MODEL OF 5-[I-125]IODO-2'-DEOXYURIDINE TREATMENT - CONTINUOUS-INFUSION REGIMENS FOR HEPATIC METASTASES

      The Journal of nuclear medicine
    96. IMBRIACO M; YEUNG HWD; MACAPINLAC H; ZHANG JJ; KEMENY N; COHEN A; FINN RD; LARSON SM
      WHOLE-BODY PET-FDG IN PATIENTS WITH RECURRENT COLORECTAL-CARCINOMA - COMPARISON WITH CT

      The Journal of nuclear medicine
    97. GOLDSMITH SJ; NARKAR AA; MEHTA BM; LARSON SM
      CHARACTERIZATION OF SERUM THYROGLOBULIN IN NL AND THYROID CA PTS BY EPITOPE-SPECIFIC IRMA

      The Journal of nuclear medicine
    98. MACAPINLAC H; YEUNG HWD; ROBBINS R; SQUIRE O; LARSON SM
      IMAGING OF HURTHLE CELL-CARCINOMA OF THE THYROID (HCT) WITH FDG PET

      The Journal of nuclear medicine
    99. SGOUROS G; LOH AC; ODONOGHUE JA; DELAND D; PURI D; CAPITELLI P; HUMM JL; LARSON SM; OLD LJ; DIVGI CR
      G250 ANTIBODY PHARMACOKINETIC PARAMETERS FOR A MODEL OF TUMOR RESPONSE IN RADIOIMMUNOTHERAPY

      The Journal of nuclear medicine
    100. IMBRIACO M; FURHANG EE; HUMM JL; YEUNG H; ELSHIRBINI A; ROBBINS R; LARSON SM
      RADIATION-DOSE TO THE SALIVARY-GLANDS DURING I-131 TREATMENT OF THYROID-CANCER - CORRELATION WITH CLINICAL FINDINGS

      The Journal of nuclear medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/05/20 alle ore 05:50:51